Skip to main content
Sarah Arron, MD, Dermatology, San Francisco, CA, San Francisco VA Medical Center

SarahTuttletonArronMD

Dermatology San Francisco, CA

Dermatologic Surgery

Assistant Professor, Dermatology, UCSF School of Medicine

Dr. Arron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arron's full profile

Already have an account?

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Dermatology, 2004 - 2006
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Transitional Year, 2003 - 2004
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2024
  • American Board of Dermatology Dermatology
  • American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FASDS) American Society for Dermatologic Surgery
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States  
    Sarah T Arron, Isaac Brownell, Matthew A Triplette, Eric A Engels, JAMA Dermatology
  • Characteristics and Skin Cancer Risk Behaviors of Adult Sunless Tanners in the United States  
    Matthew D Mansh, Eleni Linos, Ingrid Polcari, Sarah T Arron, JAMA

Lectures

  • Caring for LGBT patients: What dermatologists need to know 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Authored Content

  • Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
  • Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020

Press Mentions

  • Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests Through Multiple Oral Presentations at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting
    Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests Through Multiple Oral Presentations at the 2022 American Society for Dermatologic Surgery (ASDS) Annual MeetingOctober 10th, 2022
  • Study Finds Higher Risk of Skin Cancer After Childhood Organ Transplant
    Study Finds Higher Risk of Skin Cancer After Childhood Organ TransplantJune 28th, 2022
  • Data from Second Independent Multi-Center Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Confirms Independent Risk-Stratification Performance of DecisionDx®-SCC
    Data from Second Independent Multi-Center Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Confirms Independent Risk-Stratification Performance of DecisionDx®-SCCMay 19th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations